Audited Financial Results of the Company for quarter and financial year ended March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Prevest Denpro Limited reported standalone revenue of ₹7,166.42 lakhs for FY26, up 13.64% from ₹6,306.77 lakhs in FY25. Net profit grew 17.67% to ₹2,141.82 lakhs from ₹1,820.13 lakhs. EPS improved to ₹17.84 from ₹15.16. The company operates dental products business with 3 subsidiaries - Denvisio Biomed (India), Axiodent INC (US), and Prevest Denpro Gulf (UAE). Cash and cash equivalents stood at ₹7,264.97 lakhs with zero debt. Statutory auditors Mittal & Associates issued an unmodified (clean) opinion on both standalone and consolidated financials.
Positive results with ~18% PAT growth and strong cash position signal financial health. The clean audit opinion removes key risk concerns for investors. No debt and robust cash reserves provide buffer against economic headwinds.